Keyphrases
Liver Transplantation
100%
Acute Liver Failure
74%
Hepatitis C Virus
46%
Liver Transplant Recipients
38%
Orthotopic Liver Transplantation
36%
Hepatitis C
27%
Transplantation
27%
Chronic Hepatitis C
26%
Hepatocellular Carcinoma
25%
Interferon-α (IFN-α)
23%
Cirrhosis
21%
Liver
18%
Primary Biliary Cirrhosis
17%
Etiology
17%
Patient Survival
16%
Primary Sclerosing Cholangitis
14%
Ribavirin
14%
United States
13%
MELD Score
13%
Pretransplant
13%
Hepatitis B Virus
13%
Cholestatic Liver Disease
13%
Acetaminophen
12%
Fibrosis
12%
Virus-specific
12%
Immunosuppression
11%
Allograft
11%
End-stage Liver Disease
10%
MicroRNA
10%
Graft Survival
9%
Transplant-free Survival
9%
Hepatitis
9%
Liver Allograft
9%
Multicenter Cohort Study
9%
Risk Factors
8%
Survival Rate
8%
Recurrent Hepatitis
8%
Infected Patients
8%
Liver Disease
8%
Immune Response
7%
Solid Organ Transplantation
7%
Cirrhotic Liver
7%
Antiretroviral Therapy
7%
Hepatitis C Virus Infection
7%
Clinical Outcomes
7%
Chronic Liver Disease
7%
Hepatitis B
7%
Alpha-fetoprotein
7%
Bone Disease
7%
Prognostic Model
7%
Medicine and Dentistry
Liver Transplantation
90%
Acute Liver Failure
51%
Liver Graft
50%
Hepatitis C
27%
Diseases
24%
Hepatocellular Carcinoma
24%
Liver Disease
24%
Hepatitis C Virus
22%
Recurrent Disease
19%
Liver Cirrhosis
19%
Allograft
18%
Primary Biliary Cirrhosis
16%
Infection
14%
Primary Sclerosing Cholangitis
14%
Paracetamol
13%
Ribavirin
12%
End Stage Liver Disease
10%
Chronic Hepatitis C
10%
Cohort Analysis
9%
Immunosuppressive Treatment
9%
Graft Survival
9%
Hepatitis B Virus
9%
Hepatitis B
7%
Transcatheter Arterial Chemoembolization
7%
Fibrosis
7%
Virus
7%
Neoplasm
7%
Alpha-Fetoprotein
7%
Bone Disease
7%
Prognostic Model
7%
Model For End Stage Liver Disease Score
7%
Peginterferon
6%
Liver Injury
6%
Biopsy Technique
6%
Bone Density
6%
Lumbar Spine
6%
Retransplantation
6%
Combination Therapy
6%
Interferon
6%
Antiviral Drug
6%
Chronic Liver Disease
6%
Antiviral Therapy
5%
Liver Failure
5%
Survival Rate
5%
Hepatitis A
5%
Odds Ratio
5%
Model for End-Stage Liver Disease
5%
Wilson's Disease
5%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Liver Failure
51%
Hepatitis C
29%
Hepatitis C Virus
23%
Paracetamol
20%
Chronic Hepatitis C
17%
Infection
14%
Ribavirin
14%
Recurrent Disease
14%
Interferon
14%
Diseases
13%
Liver Disease
13%
Liver Cell Carcinoma
13%
End Stage Liver Disease
12%
microRNA
12%
Survival Rate
10%
Liver Cirrhosis
9%
Fibrosis
8%
Liver Injury
8%
Hepatitis B Virus
7%
Neoplasm
7%
Cohort Study
7%
Primary Biliary Cirrhosis
6%
Peginterferon
6%
Hepatitis B
6%
HIV
6%
Vitamin D-Binding Protein
6%
Lamivudine
6%
Chronic Hepatitis B
6%
Isoniazid
6%
Tacrolimus
6%
Ciclosporin
6%
Ursodeoxycholic Acid
6%
Alpha Interferon
6%
Antiviral Drug
6%
Tolerability
5%
Virus Hepatitis
5%
Antiviral Therapy
5%
Hepatitis A
5%
Alpha2b Interferon
5%
Liver Failure
5%
Wilson's Disease
5%